Efficacy of first-line treatments for patients (pts) with advanced EGFR mutated NSCLC: Network meta-analysis of TKI monotherapy and combinations trials. This is an ASCO Meeting Abstract from the 2021 ...
Molecular Correlates of Long-Term Response to Bevacizumab in Glioblastoma Recurrent nonkinase domain FGFR VUS variants were collected from the Catalog of Somatic Mutations in Cancer and their ...
Development of FGFR inhibitors, which target fibroblast growth factor receptors, is among the most important advances in the treatment of cholangiocarcinoma. The FDA has accepted Taiho Oncology’s ...
Cellular signaling pathways control the proliferation, differentiation, survival, and migration of normal cells. But, dysregulation of these cells can cause tumors to form and grow. The overexpression ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results